Ourobionics is a leading biotechnology startup, founded in 2021 and headquartered in The Netherlands. Their slogan, "We take you Beyond Bioprinting," embodies their pioneering approach. Ourobionics leverages advanced electric, magnetic, and microfluidic 3D biofabrication technology, along with cyborganic technology, to create high throughput tissues and organs with embedded bioelectronics, biosensors, and therapeutic agents. This innovative approach goes beyond traditional bioprinting, opening doors for next-generation applications in regenerative medicine, medical devices, and human-machine interfaces.
Despite their groundbreaking innovations, the company's last investment details are not available at this time. However, Ourobionics' unique technology and ambitious vision position them as an intriguing prospect for venture capitalists seeking to invest in the future of biotechnology and regenerative medicine.
There is no investment information
No recent news or press coverage available for Ourobionics.